000307462 001__ 307462
000307462 005__ 20251231120305.0
000307462 0247_ $$2doi$$a10.1053/j.semnuclmed.2025.12.003
000307462 0247_ $$2pmid$$apmid:41453817
000307462 0247_ $$2ISSN$$a0001-2998
000307462 0247_ $$2ISSN$$a1558-4623
000307462 037__ $$aDKFZ-2025-03061
000307462 041__ $$aEnglish
000307462 082__ $$a610
000307462 1001_ $$0P:(DE-HGF)0$$aCivan, Caner$$b0
000307462 245__ $$aThe value of PSMA PET for risk stratification in prostate cancer: an update and future aspects.
000307462 260__ $$aNew York, NY [u.a.]$$bElsevier$$c2025
000307462 3367_ $$2DRIVER$$aarticle
000307462 3367_ $$2DataCite$$aOutput Types/Journal article
000307462 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1767095852_1386405$$xReview Article
000307462 3367_ $$2BibTeX$$aARTICLE
000307462 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000307462 3367_ $$00$$2EndNote$$aJournal Article
000307462 500__ $$aepub
000307462 520__ $$aPSMA-PET has become a pivotal imaging method for staging and restaging of prostate cancer. Risk stratification of the disease is a crucial for the patients to receive most appropriate treatment, and for the clinicians to follow the patients more precisely. PSMA-PET provides non-invasive biomarkers for the risk assessment of prostate cancer, offering prediction of clinical outcomes. PROMISE criteria have been developed as comprehensive and integrated framework demonstrating association with overall survival. In this review, we aim to provide a brief update of the prognostic value of PSMA-PET for risk assessment in prostate cancer.
000307462 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000307462 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000307462 650_7 $$2Other$$aAssessment
000307462 650_7 $$2Other$$aCT
000307462 650_7 $$2Other$$aPET
000307462 650_7 $$2Other$$aPSMA
000307462 650_7 $$2Other$$aProstate cancer
000307462 650_7 $$2Other$$aRisk
000307462 7001_ $$0P:(DE-HGF)0$$aKarpinski, Madeleine J$$b1
000307462 7001_ $$aRahbar, Kambiz$$b2
000307462 7001_ $$0P:(DE-HGF)0$$aFendler, Wolfgang P$$b3
000307462 7001_ $$0P:(DE-HGF)0$$aHerrmann, Ken$$b4
000307462 773__ $$0PERI:(DE-600)2133379-8$$a10.1053/j.semnuclmed.2025.12.003$$gp. S0001299825001813$$pnn$$tSeminars in nuclear medicine$$vnn$$x0001-2998$$y2025
000307462 909CO $$ooai:inrepo02.dkfz.de:307462$$pVDB
000307462 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000307462 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000307462 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000307462 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000307462 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000307462 9141_ $$y2025
000307462 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-27$$wger
000307462 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSEMIN NUCL MED : 2022$$d2024-12-27
000307462 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-27
000307462 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000307462 980__ $$ajournal
000307462 980__ $$aVDB
000307462 980__ $$aI:(DE-He78)ED01-20160331
000307462 980__ $$aUNRESTRICTED